Product Information
JND3229 is a synthetic, non-small-cell EGFR inhibitor that targets the kinase domain of EGFR. It has been shown to inhibit the proliferation of mutant EGFR cell lines in vitro and in vivo, as well as tumor growth in xenograft models. JND3229 has also been shown to suppress tumor growth and prolong survival in a mouse model of metastatic cancer. The mechanism of action for this drug is inhibition of the tyrosine kinase activity that is essential for the activation of downstream signaling pathways.
Chemical properties
Technical inquiry about: 3D-KQD88664 JND3229
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
